Management of pancreatic adenocarcinoma in Ontario, Canada: A population-based study using novel case ascertainment

Canadian Journal of Surgery

Volumn 54, Issue 1, 2011, Pages 54-60

  Borgida, Ayelet Eppel ^a,b   Ashamalla, Shady ^c   Al Sukhni, Wigdan ^a,d   Rothenmund, Heidi ^a,d   Urbach, David ^e   Moore, Malcolm ^c   Michelle Cotterchio, ^c   Gallinger, Steven ^a,b  

^a Pediatric Oral and Maxillofacial Surgery   (Canada)

^b Zane Cohen Centre for Digestive Diseases Clinical Research Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551563335     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.026409     Document Type: Article

References (20)

1. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Toronto (ON): Canadian Cancer Society; 2009.
2. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1-7.
3. Warshaw AL, Fernández-del Castillo. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
4. Nitecki SS, Sarr MG, Colby TV, et al. Long term survival after resection of ductal adenocarcinoma of the pancreas: Is it really improving? Ann Surg 1995;221:59-66.
5. Alexakis N, Halloran C, Raraty M, et al. Current standards of surgery for pancreatic cancer. Br J Surg 2004;91:1410-27.
6. Simunovic M, To T, Theriault M, et al. Relation between hospital surgical volume and outcome for pancreatic resection for neoplasm in a publicly funded health care system. CMAJ 1999;160:643-8.
7. Newman EA, Simeone DM, Mulholland M. Adjuvant treatment strategies for pancreatic cancer. J Gastrointest Surg 2006;10:916-26.
8. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-10.
9. Pawlik TM, Abdalla EK, Barnett CC, et al. Feasibility of a randomized trial for extended lymphadenectomy for pancreatic cancer. Arch Surg 2005;140:584-9.
10. Sullivan T. Cancer registry project passes midterm exam. CAP TODAY December 2005.
11. Petersen GM, de Andrade M, Goggins M, et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006;15:704-10.
12. Sobin LH, Wittekind C, editors. UICC TNM classification of malignant tumours. 6th ed. New York (NY): Wiley-Liss; 2002.
13. Nuzzo G, Clemente G, Greco F, et al. Is the chronologic age a contra-indication for surgical palliation of unresectable periampullary neoplasms? J Surg Oncol 2004;88:206-9.
14. Nkondjock A, Krewski D, Johnson KC, et al. Canadian cancer registries epidemiology research group. Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer 2005;92:971-7.
15. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trial. JAMA 2004;291:2720-6.
16. Lai GY, Gary TL, Tilburt J, et al. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials 2006;3:133-41.
17. Townsley C, Pond GR, Peloza B, et al. Analysis for treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol 2005;23:3802-10.
18. Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg 2007;246:173-80.
19. Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346: 1128-37.
20. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349:2117-27.